Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Placzek

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The New England Journal of Medicine|May 27, 2026
Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart FailureWolfram-Hubertus Zimmermann, Stephan Ensminger, Ingo Kutschka, et al.
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.
JAMA|March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical TrialStefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
The New England Journal of Medicine|August 31, 2024
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationStefan D Anker, Tim Friede, Ralph-Stephan von Bardeleben, et al.
Journal of the American College of Cardiology|September 1, 2024
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2Piotr Ponikowski, Tim Friede, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|June 7, 2024
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trialsStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The New England Journal of Medicine|May 27, 2026
Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart FailureWolfram-Hubertus Zimmermann, Stephan Ensminger, Ingo Kutschka, et al.
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
European Journal of Heart Failure|April 29, 2025
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trialsStefan D Anker, Tim Friede, Javed Butler, et al.
JAMA|March 30, 2025
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical TrialStefan D Anker, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
The New England Journal of Medicine|August 31, 2024
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationStefan D Anker, Tim Friede, Ralph-Stephan von Bardeleben, et al.
Journal of the American College of Cardiology|September 1, 2024
Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2Piotr Ponikowski, Tim Friede, Ralph Stephan von Bardeleben, et al.
European Journal of Heart Failure|June 7, 2024
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trialsStefan D Anker, Tim Friede, Ralph Stephan von Bardeleben, et al.
Pageof 3